Oral Bevacizumab-800CW and Cetuximab-800CW Administration to Detect Early Esophageal Adenocarcinomas

Clinical trial NCT05745857 · RECRUITING

Trial details

NCT number: NCT05745857
Sponsor: University Medical Center Groningen
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Barrett's Esophagus Without Dysplasia Barrett Oesophagitis With Dysplasia Esophageal Adenocarcinoma

Start date: 2023-09-15
Primary completion: 2026-05-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.